No­vavax trims $50M in costs but did not re­duce head­count, CEO says

Covid-19 vac­cine man­u­fac­tur­er No­vavax cut $50 mil­lion worth of ex­pens­es in the first quar­ter of this year but did not lay off any staff, CEO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.